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Introduction
Diabetes mellitus affects approximately 20.6 million
people in the USA (1). Of these, an estimated 6.2
million, nearly one-third of the affected population,
are unaware that they have the disease. Diabetes
mellitus is the ﬁfth deadliest disease in the USA, and
more than a million people develop the disease each
year. Economic costs associated with diabetes mell-
itus are estimated to be approximately $132 billion
annually (2).
The primary risk factors for the development of
type 2 diabetes mellitus (T2D) are overweight, seden-
tary, ‡ age of 45 years and⁄or a family history of
diabetes mellitus (1). African Americans, Latinos and
Native Americans are at increased risk, as are women
who have had babies weighing more than 9 pounds
at birth (1). Diabetes mellitus is a chronic disease
that requires ongoing monitoring and treatment. Its
associated complications include blindness, kidney
disease, nerve damage and cardiovascular disease
(CVD). CVD and stroke account for 65% of deaths
in persons with diabetes mellitus, and individuals
with diabetes mellitus experience a CVD death rate
2–4 times higher than adults without diabetes mell-
itus (3).
As increasingly evidenced in the literature, diabetes
mellitus substantially affects patients’ health-related
quality of life (HRQoL) (4–7). More than two dozen
different quality of life instruments have been used
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SUMMARY
Objectives: This study compared health-related quality of life (HRQoL) and
depression among individuals with type 2 diabetes mellitus (T2D) and those at low
or high risk for T2D. Methods: Respondents in a population-based US 2004 sur-
vey reported whether they had T2D (n = 3530) or risk factors for T2D [abdominal
obesity, body mass index (BMI) ‡ 28 kg⁄m
2, dyslipidaemia, hypertension and his-
tory of cardiovascular disease]. Respondents without T2D were stratiﬁed into low
risk (0–2 risk factors, n = 5335) and high risk (3–5 risk factors, n = 5051). SF-12
version 2 (SF-12) and Patient Health Questionnaire (PHQ)-9 were used to measure
HRQoL and depression. Mean scores were compared across the three groups using
analysis of variance. Linear regression identiﬁed factors associated with SF-12
Physical and Mental Component Summary scores (PCS and MCS), adjusting for
age, gender, race, income, geographic region, household size, BMI and group.
Results: Respondents were mostly women (60%) with mean age of 54 years.
Mean PCS scores for T2D and high risk (39.5 and 41.7, respectively) were signiﬁ-
cantly lower than for low risk (50.6, p < 0.001). After adjustment, high-risk and
T2D groups were associated with lower PCS and MCS scores compared with low
risk group (p < 0.05). Mean PHQ-9 scores and per cent with moderate-to-severe
depression were signiﬁcantly higher for T2D and high risk than for low risk
(p < 0.01). Conclusions: Health-related quality of life and depression scores in
T2D were similar to those at high risk, and indicated signiﬁcant decrements in
physical health and greater depression compared with low-risk respondents.
What’s known
Previous studies have documented that diabetes, its
treatment, complications and comorbidities
adversely affect health-related quality of life among
patients with diabetes. Additionally, depressive
symptoms are common among patients with
diabetes.
What’s new
This study provides new evidence of the burden of
being at high risk for diabetes on health-related
quality of life and depressive symptoms, bringing
attention and recognition that quality of life is
affected in those not diagnosed with type 2
diabetes but at high risk of developing the disease.
Also, the present study observed the impact of type
2 diabetes on quality of life in a large
representative sample of individuals treated in usual
clinical practice.
doi: 10.1111/j.1742-1241.2008.01703.x
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itus. For those living with diabetes mellitus, the
impact of treatments, complications and comorbidi-
ties has been documented to adversely affect
HRQoL (8). Additionally, depressive symptoms are
common among patients with diabetes (9). However,
limited information is available on the HRQoL and
depression of those without T2D but at high risk for
developing this condition. The Study to Help
Improve Early evaluation and management of risk
factors Leading to Diabetes (SHIELD) is a 5-year,
survey-based study conducted to better understand
patterns of health behaviour, knowledge and atti-
tudes of people living with diabetes mellitus, and
those with varying levels of cardiometabolic risk. The
present investigation is a cross-sectional analysis
designed to assess and compare the HRQoL and
depression among individuals with T2D and those at
low or high risk for T2D to determine if the burden
is similar among at-risk individuals. Findings from
this study will provide a better understanding of the
unmet medical needs and burden of illness in the
T2D and at-risk populations.
Methods
A detailed questionnaire (baseline survey) was mailed
in 2004 to 22,001 individuals, age 18 years and older
who were identiﬁed with diabetes or risk factors
associated with diabetes. The baseline survey assessed
comorbid conditions, health status, knowledge, atti-
tudes and current behaviours related to general
health and diabetes, and HRQoL and depression. A
response rate of 80% was achieved for the baseline
survey. A detailed description of the SHIELD meth-
odology has been published elsewhere (10,11).
The sample source for the baseline survey was
selected from respondents to a screening survey
mailed to a stratiﬁed random sample of 200,000 US
households, representative of the US population for
age of head of household, income, household size,
urban density and census region, identiﬁed by the
Taylor Nelson Sofres National Family Opinion panel
(TNS, Greenwich, CT). The screening questionnaire
was completed by the head of household, who
answered for up to four adult household members.
Responses were received from 211,097 adults for a
response rate of 64%. Postweighting of the SHIELD
data was performed to correct for over- or under-
sampling of some demographic groups and to ensure
that respondents represented the US Census popula-
tion (12) in terms of geographic residence, age of the
head of household, household size and income.
Respondents to the screening and baseline surveys
were classiﬁed according to diagnosis of diabetes
(type 1 or type 2) and risk factors associated with
increased risk of T2D. Recognised risk factors,
derived from the literature, national guidelines and
expert opinion (13,14), included: (i) abdominal obes-
ity (deﬁned as waist circumference ‡ 97 cm for men
and ‡ 89 cm for women), (ii) body mass index
(BMI) ‡ 28 kg⁄m
2 (general obesity), (iii) diagnosis
of dyslipidaemia (cholesterol problems), (iv) diagno-
sis of hypertension (high blood pressure) and (v)
diagnosis of CVD (deﬁned as one or more of heart
disease, myocardial infarction, narrow or blocked
arteries, stroke, coronary artery bypass graft surgery,
angioplasty, stents or surgery to clear arteries). Recei-
ver operating characteristic (ROC) curves were com-
puted for all possible cutoff points for BMI and
waist circumference and the level for which the area
under the curve was maximised (maximises the
number of T2D respondents correctly classiﬁed) was
chosen as the optimal cutoff point. The abdominal
obesity and BMI cutoff-points are similar to those
recommended by the National Cholesterol Education
Program and National Heart, Lung, and Blood Insti-
tute (14,15). Stepwise logistic regression analyses
veriﬁed that these ﬁve risk factors were indepen-
dently and equally associated with diabetes diagnosis
in the SHIELD population. Respondents with zero,
one or two of the ﬁve risk factors were further
classiﬁed as low risk for diabetes and respondents
with 3–5 risk factors were classiﬁed as high risk.
ROC curves for all possible cutoff points of the risk
factor score were evaluated and maximised when
three or more risk factors were present.
Measures
12-item Short Form version 2
The SF-12v2  Health Survey (SF-12; Quality Metric
Inc., Lincoln, RI, USA), the short form of the widely
used SF-36, is a brief and reliable measure of overall
health status (16). The SF-12 measures eight domains
of health: physical functioning, role limitations
because of physical health (role-physical), bodily
pain, general health perceptions, vitality, social func-
tioning, role limitations because of emotional prob-
lems (role-emotional) and mental health. The recall
period for the SF-12 was the past 4 weeks. SF-12
responses were scored from 0 to 100 on each of the
domains, as well as for the Physical Component
Summary (PCS) scale and Mental Component
Summary (MCS) scale. Higher scores indicate better
HRQoL. To simplify comparisons with the general
population, norm-based scoring was used. In norm-
based scoring, scores are linearly transformed to a
scale with a mean of 50 and standard deviation (SD)
of 10 for the general US population (16).
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The Patient Health Questionnaire (PHQ)-9 focuses on
the nine signs and symptoms of depression from the
Diagnostic and Statistical Manual of Mental Disorders,
Fourth edition (DSM-IV) (17). The PHQ-9 is a dual-
purpose instrument that is used to establish a provi-
sional depressive disorder diagnosis as well as provide
a symptom severity score. Higher scores indicate
increasing severity of depression. For a diagnosis of
depression, ﬁve or more items must be scored as
present more than half of the days or nearly every day.
PHQ-9 scores of 5–9 indicate minimal depressive
symptoms, scores of 10–14 indicate minor depression
or major depression that is mild, scores of 15–19 is
major depression, moderately severe and scores ‡ 20
indicate major depression, severe (17).
Statistical analyses
For each group (T2D, high risk, low risk), we
reported mean scores overall for SF-12 PCS and MCS
and PHQ-9. Statistical comparisons across groups
were made using analysis of variance (ANOVA) with
Fisher’s least signiﬁcant difference post hoc testing,
with p < 0.01 considered signiﬁcant. Signiﬁcance test-
ing comparing groups on HRQoL and depression
scores was performed, with emphasis on comparisons
between the T2D group and the high- and low-risk
groups. Additionally, multivariable linear regression
modelling was used to identify those factors that most
affected respondents’ HRQoL. Dependent HRQoL
variables were the PCS score and the MCS score of
the SF-12. Explanatory factors included socio-demo-
graphic factors such as age, gender, race, geographic
region, household income, as well as BMI category
(normal weight, overweight or obese) and group sta-
tus (low risk, high risk or T2D).
Results
Greater than 70% of each cohort (5335⁄7403 for
low risk, 5051⁄6742 for high risk and 3530⁄5000
for T2D) completed the SF-12 and PHQ-9 ques-
tions. T2D respondents were signiﬁcantly older
than high- and low-risk respondents (Table 1). The
T2D respondents also were signiﬁcantly less likely
to be white, have some college or higher educa-
tion, and more likely to have lower incomes than
high- and low-risk respondents. There was a signif-
icantly greater proportion of women in the low-
risk group compared with T2D and high-risk
groups (Table 1). A history of cardiovascular
events had the lowest prevalence among all groups,
while abdominal obesity and BMI obesity were
concomitant in the majority of respondents in each
group (Table 1).
SF-12 PCS and MCS scores
Mean SF-12 PCS scores for respondents with T2D
and those with high risk [39.5 (SD 12.9) and 41.7
(SD 12.3), respectively] were signiﬁcantly lower than
the low-risk group [50.6 (SD 9.9), p < 0.001 for
each] (Figure 1). The mean PCS score for T2D
respondents was statistically signiﬁcantly lower than
the mean for the high-risk group (p < 0.001).
In contrast, there were no statistically signiﬁcant
differences across groups in mean SF-12 MCS scores
(Figure 1). In addition, mean MCS scores were not
signiﬁcantly different from the US population norm
of 50, with mean scores of 49.52 (SD = 10.1) for the
low-risk group, 49.04 (11.0) for high risk and 49.01
(10.9) for T2D groups.
Examination of SF-12 domain results revealed that
scores for the T2D and high-risk groups were signiﬁ-
Table 1 Patient characteristics of SHIELD respondents completing the SF-12 and PHQ-9
Characteristics T2D (n = 3530) High risk (n = 5051) Low risk (n = 5335)
Age, years, mean (SD) 59.7 (13.0) 58.5 (14.6)** 46.2 (16.0)*
Gender, % women 57 56 65*
Race, % white 85 89** 88*
Education, % with some college or higher 65 68** 75*
Income, % with < $40,000⁄year 51 46** 36*
Risk factors
Abdominal obesity, % 86 96 46*
BMI ‡ 28 kg⁄m
2, % 77 88 34*
Hypertension, % 67 76 12*
Dyslipidaemia, % 73 81 20*
Cardiac event, % 29 36 4*
*p < 0.01, T2D vs. low risk. **p < 0.01, T2D vs. high risk. SHIELD, Study to Help Improve Early evaluation and management of risk
factors Leading to Diabetes; PHQ, Patient Health Questionnaire; T2D, type 2 diabetes mellitus; BMI, body mass index.
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domains (p < 0.01). In addition, mean scores for the
T2D group were signiﬁcantly lower than those for
the high-risk group (p < 0.01) in all domains except
mental health.
Linear regression models
Income, age, BMI, gender, race, geographic region,
household size and T2D risk status were signiﬁcantly
associated with HRQoL (Table 2). T2D risk status
was signiﬁcantly associated with HRQoL, such that
those with T2D had the lowest HRQoL (p < 0.001
vs. low-risk group for PCS and MCS). The decrease
in MCS was relatively smaller than in PCS and about
equal for the high-risk and T2D groups (approxi-
mately )1.7), but signiﬁcantly different than low-risk
group, p < 0.05.
For both PCS and MCS, as household incomes
decreased, respondents’ HRQoL decreased, such that
those with incomes < $22,500 reported the greatest
impact on HRQoL (p < 0.001 vs. ‡ $90,000 in both
models, Table 2). Increasing age was associated with
decreased physical HRQoL, such that individuals
age 75 years and older reported the greatest impact
on HRQoL (p < 0.001 vs. those aged 35–44), with
those aged 18–24 years reporting the highest
HRQoL. MCS analysis, however, showed the older
age groups, aged 65–74 and ‡ 75 in particular, were
more likely to report higher HRQoL in this domain
(p < 0.001 for both age groups vs. those aged 35–
44, Table 2). For both PCS and MCS, being obese
was associated with lower HRQoL, although this
decrease was greater for PCS than for MCS. Female
gender, other race (Asian, Paciﬁc Islander, American
Indian, Aleut Eskimo and Other), East South Cen-
tral geographic location, and a household size > 5
also were associated with a negative impact on
HRQoL.
PHQ-9 scores
Mean PHQ-9 summed score was signiﬁcantly lower
(indicating lower rates of depression) in the low-risk
group (3.66) than in either the high-risk (5.28) or
T2D (5.43) groups (p < 0.01, Table 3). When cate-
gorised into level of depression, low-risk respondents
were more likely to have no-to-minimal depression
than the high-risk or T2D groups (69.8% vs. 58.4%
and 57.2%, respectively, p < 0.01) and less likely to
have moderate-to-severe depression (11.3% vs.
18.1% and 19.6%, respectively, p < 0.01) (Table 3).
For each of the nine questions in the PHQ-9, T2D
and high-risk respondents reported signiﬁcantly
greater frequency of depressive symptoms than the
low-risk respondents, p < 0.01.
Discussion
In this study, we assessed HRQoL and depression to
evaluate the overall burden of T2D and associated
risk factors on general health status (SF-12) and
more speciﬁcally on mental health (PHQ-9). The
SHIELD data demonstrate that respondents with
T2D and those with a high number of risk factors
(3–5) have a self-reported lower HRQoL, compared
with those having a lower number of risk factors
(0–2), as well as the general population. Respondents
with T2D and those with high risk reported signiﬁ-
cant decrements in physical health HRQoL compared
with those with low risk, even after adjusting for
modiﬁable and non-modiﬁable characteristics. Nearly
50% of those with T2D and those with high risk
reported some limitation in the physical component,
including work or moderate activities. This study
also provided new evidence of decreased HRQoL and
increased depressive symptoms among individuals
at high risk for T2D but who were not currently
diagnosed or treated as well as among those with
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in respondents with T2D and those at high risk of
T2D were remarkably similar but signiﬁcantly differ-
ent from low-risk respondents. This observation may
indicate that the accumulation of risk factors for
T2D is altering HRQoL before a diagnosis is made.
Additionally, these results showed that health and
disease status affected the emotional health of those
with T2D and those with high risk in greater propor-
tion than reported by the lower-risk group. In gen-
eral, HRQoL decrements were greater for physical
domains than for emotional or mental domains, but
depression as measured by the PHQ-9 was signiﬁ-
cantly greater in the T2D and high-risk groups. A
greater percentage of respondents with T2D and with
high risk reported being moderately to severely
depressed compared with the low-risk group.
Also evident in this study was the impact that
demographic factors, such as age and income, have
on individuals’ HRQoL. Those respondents with
lower incomes, increased age, and who were obese,
at high risk or with a T2D diagnosis reported lower
HRQoL scores, after adjusting for non-modiﬁable
risk factors (gender, race, geographic region and
household size). These ﬁndings conﬁrmed those in
the Canadian National Population Survey, (18)
where T2D had a greater impact on HRQoL for
older ages and low socio-economic status.
The present study conﬁrms the lower HRQoL
among T2D respondents that has been observed in
other investigations (4–7,18–22). Impaired physical
and social functioning but not mental functioning
among diabetes mellitus patients was observed in the
present study as well as prior studies that utilised the
SF-36 general measure (19,20,22). Moreover, the
present study observed the impact of T2D on
HRQoL in a signiﬁcantly larger population-based
sample (n = 3530 T2D) than previous investigations
(n = 221–254) (19,21). However, these prior investi-
gations typically compared T2D patients with the
general population (18–21), whereas this study dem-
onstrated lower HRQoL among T2D and high-risk
respondents when compared with low-risk respon-
dents. The greater number of risk factors for T2D
signiﬁcantly impacted HRQoL in our study sample,
similar to analyses of the Medical Expenditure Panel
Survey, which showed that individuals with a cluster
of similar cardiometabolic risk factors had a signiﬁ-
cant decrease in physical functioning (PCS-12) but
not mental functioning (22).
The MCS of the SF-12 did not differentiate risk
groups as well as the PCS. The MCS scores were sig-
niﬁcantly higher for the low-risk than the high-risk
or T2D groups, only after adjusting for other covari-
ates such as age, race and gender. Further, the mental
Table 2 Multivariate stepwise linear regression analyses
of variables impacting health-related quality of life in
SHIELD respondents*
Beta coefﬁcient (SE)
Signiﬁcant variables
Physical
Component
Score
Mental
Component
Score
Diabetes risk⁄diagnosis
0–2 risk factors (reference) (reference)
3–5 risk factors )4.82 (0.25) )1.71 (0.24)
Type 2 diabetes )6.53 (0.27) )1.72 (0.25)
Income ($)
< 22,500 )7.81 (0.29) )5.42 (0.28)
22,500–39,999 )4.45 (0.30) )2.94 (0.28)
40,000–59,999 )2.76 (0.30) )1.56 (0.29)
60,000–89,999 )1.40 (0.30) )1.18 (0.29)
‡ 90,000 (reference) (reference)
Age (years)
18–24 1.80 (0.56) 1.59 (0.53)
25–34 1.00 (0.38) )1.26 (0.36)
35–44 (reference) (reference)
45–54 )2.82 (0.30) 1.42 (0.29)
55–64 )4.62 (0.32) 3.62 (0.30)
65–74 )5.27 (0.34) 6.30 (0.32)
‡ 75 )8.78 (0.36) 5.40 (0.35)
BMI (kg⁄m
2)
Underweight (< 18.5) Dropped )1.63 (0.81)
Normal weight
(18.5–24.9)
(reference) (reference)
Overweight (25.0–29.9) Dropped Dropped
Obese (> 30) )4.00 (0.21) )0.75 (0.20)
Female )2.31 (0.19) )1.90 (0.18)
Male (reference) (reference)
Race
White (reference) (reference)
Black 0.95 (0.34) 0.76 (0.33)
Other )1.34 (0.56) )1.10 (0.54)
Geographic region
East South Central )1.41 (0.37) )0.71 (0.36)
New England 1.01 (0.42) Dropped
West North Central Dropped 0.93 (0.34)
East North Central Dropped 0.52 (0.23)
Paciﬁc (reference) (reference)
Household size
1 (reference) (reference)
3 Dropped )0.89 (0.24)
‡ 5 )0.71 (0.32) )1.31 (0.31)
*Scores indicate change from reference group: gender = male,
race = white, household income = ‡ $90,000, age = 35–44,
BMI = normal weight, group = low risk, geographic region = -
Paciﬁc, household size = 1. p < 0.05 vs. reference group for
all values. Dropped = level of variable dropped from model
during stepwise regression, no beta coefﬁcient computed.
SHIELD, Study to Help Improve Early evaluation and manage-
ment of risk factors Leading to Diabetes; BMI, body mass index.
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risk groups as well as the PHQ-9 depression ques-
tionnaire. The PHQ-9 scores demonstrated that the
low-risk group had signiﬁcantly lower scores and
smaller per cent of respondents with moderate-to-
severe depression compared with the high-risk and
T2D groups. Signiﬁcant differences were observed
among the low-risk as compared with the high-risk
and T2D respondents for each of the nine items in
the PHQ-9. These ﬁndings may indicate that the
mental health component of the SF-12 may not be
sufﬁciently sensitive to differentiate the groups on
the impact of risk status on depression, whereas the
PHQ-9 was especially as the MCS is a more general
assessment of emotional problems and their impact
on work, daily activities and social activities rather
than depressive symptoms. The PHQ-9 not only has
nine focused questions on depressive symptoms but
also is more speciﬁc than the MCS for frequency of
symptoms (not at all, several days, more than half
the days and nearly every day).
This study provides evidence of the impact on
HRQoL and depression in a large sample of T2D,
high-risk and low-risk groups with a high survey
response rate who are representative of the US popu-
lation. Additionally, the evaluation of HRQoL and
depression was carried out using standardised, vali-
dated measures so that normative-based results are
provided. However, there are limitations to the study
that should be considered. Only a small percentage
(5–8%) of consumers invited to participate in the
TNS panel elect to do so and those who participate
are accustomed to completing surveys, leading to the
possibility of selection bias. Household panels tend
to under-represent the very wealthy and very poor
segments of the population, and do not include mili-
tary or institutionalised individuals. However, these
limitations are true for most random sampling and
clinically based methodologies. Additionally, the
determination of T2D, high-risk and low-risk status
was made based upon self-report rather than clinical
or laboratory measures for blood glucose, hyperten-
sion, cholesterol, height and weight. It should also be
noted that other comorbidities in the high-risk
respondents, as well as those diagnosed with T2D,
may contribute to their overall health burden and
HRQoL. However, it is difﬁcult to disentangle the
HRQoL effects of such comorbidities from those of
the risk factors or T2D, as many of these conditions
are related to or a result of having the risk factors or
T2D.
Conclusions
The SHIELD results show that respondents with T2D
and those at high risk for T2D report decreased
HRQoL and increased depression compared with
respondents with lower cardiometabolic risk or the
general population, highlighting the unmet need and
burden of illness among these groups. It is important
to recognise that HRQoL is affected in those not yet
diagnosed with T2D but at high risk of developing
T2D. There may be potential opportunities to impact
the risk factors leading to T2D, which may amelio-
rate the negative impact on HRQoL and depression
and allow interventions to work in these at-risk indi-
viduals. Educating clinicians that their high-risk
patients who may not yet be diagnosed with T2D are
at risk of decreased HRQoL and depression may
improve clinicians’ awareness and increase the
opportunity for risk management and treatment. It
also may be beneﬁcial for clinicians to educate and
counsel high-risk patients to manage hypertension
and cholesterol levels as well as reduce their weight,
which subsequently may lower the patients’ potential
for poor HRQoL and depression. Further study is
needed to determine the beneﬁt of targeting health-
care interventions in high-risk and T2D patients on
reduction of HRQoL impact, and the overall health
and economic burden this may ameliorate.
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